FrancophonIA/ELRC3.0 huggingface dataset:
English: Zinforo is administered by intravenous infusion over 5 to 60 minutes for standard dose or 120 minutes for high dose (for cSSTI caused by S. aureus with MIC of 2 or 4 mg/L to ceftaroline) in infusion volumes of 50 mL, 100 mL or 250 mL (see section 6.6).
Danish: Zinforo indgives som intravenøs infusion over 5-60 minutter for standarddosen eller 120 minutter for den høje dosis (for cSSTI forårsaget af S. aureus med ceftarolin MIC på 2 eller 4 mg/l) ved et infusionsvolumen på 50 ml, 100 ml eller 250 ml (se pkt.
English: No clinical drug-drug interaction studies have been conducted with ceftaroline fosamil.
Danish: Der er ikke udført kliniske lægemiddelinteraktionsstudier med ceftarolinfosamil.
English: Ceftaroline should be used with caution in patients with a history of non-severe hypersensitivity reactions to any other beta-lactam antibiotics (e.g. penicillins or carbapenems).
Danish: Ceftarolin bør anvendes med forsigtighed til patienter, der tidligere har haft ikke-alvorlige overfølsomhedsreaktioner over for andre betalaktamantibiotika (f.eks. penicilliner eller carbapenemer).
English: Posology The recommended durations of treatment are 5-14 days for cSSTI and 5-7 days for CAP.
Danish: Dosering Den anbefalede behandlingsvarighed er 5-14 dage for cSSTI og 5-7 dage for CAP.
English: The interaction potential of ceftaroline or ceftaroline fosamil on medicinal products metabolised by CYP450 enzymes is expected to be low since they are not inhibitors nor inducers of CYP450 enzymes in vitro.
Danish: Sandsynligheden for at ceftarolin eller ceftarolinfosamil interagerer med lægemidler, der metaboliseres af CYP450-enzymer, forventes at være lav, eftersom de ikke er hæmmere eller inducere af CYP450enzymer in vitro.
English: Communityacquired pneumonia (CAP)
Danish: Samfundserhvervet pneumoni (CAP)
English: 400 mg c/every 12 hours
Danish: 400 mg c/hver 12. time
English: Anaerobic micro-organisms Gram-positive micro-organisms
Danish: Anaerobe mikroorganismer Grampositive mikroorganismer
English: The contents of Zinforo vial should be reconstituted with 20 mL of sterile water for injections.
Danish: Indholdet i Zinforo-hætteglas skal rekonstitueres med 20 ml sterilt vand til injektion.
English: Note that: There are no clinical trial data regarding the use of ceftaroline to treat CAP due to S. aureus with ceftaroline MICs > 1 mg/L 2.
Danish: Bemærk at: Der findes ingen data fra kliniske studier omkring anvendelse af ceftarolin til behandling af CAP, der skyldes S. aureus med ceftarolin MIC'er > 1 mg/l 2.
English: Adolescents aged from 12 to < 18 years with bodyweight ≥ 33 kg
Danish: Unge i alderen 12 år til < 18 år med legemsvægt ≥ 33 kg
English: Do not use Zinforo:
Danish: Brug ikke Zinforo
English: Immediate and severe hypersensitivity (e.g. anaphylactic reaction) to any other type of beta-lactam antibacterial agent (e.g. penicillins or carbapenems).
Danish: Akut og alvorlig overfølsomhed (f.eks anafylaktisk reaktion) over for et hvilket som helst andet betalaktamantibiotikum (f.eks. penicilliner eller carbapenemer).
English: Hepatic impairment No dosage adjustment is considered necessary in patients with hepatic impairment (see section 5.2).
Danish: Nedsat leverfunktion Dosisjustering er ikke nødvendig hos patienter med nedsat leverfunktion (se pkt.
English: In pooled human liver microsomes, metabolic turnover was low for ceftaroline, indicating that ceftaroline is not metabolised by hepatic CYP450 enzymes.
Danish: I puljede humane levermikrosomer var den metaboliske omsætning lav for ceftarolin, hvilket tyder på, at ceftarolin ikke metaboliseres af CYP450-enzymer i leveren.
English: The mean plasma ceftaroline M-1 to ceftaroline AUC ratio following a single 600 mg intravenous infusion of ceftaroline fosamil in healthy subjects is approximately 20-30%.
Danish: Den gennemsnitlige AUC-ratio mellem ceftarolin M-1 og ceftarolin i plasma efter en enkelt intravenøs infusion af ceftarolinfosamil på 600 mg til raske forsøgspersoner er ca. 20-30 %.
English: • Staphylococcus aureus (methicillin-susceptible strains only)
Danish: • Staphylococcus aureus (kun methicillin-følsomme stammer)
English: There are limited clinical trial data on the use of ceftaroline to treat cSSTI caused by S. aureus with an MIC of > 1 mg/L.
Danish: Der er begrænsede data fra kliniske studier om anvendelse af ceftaroline til behandling af cSSTI, der skyldes S. aureus med en MIC på > 1 mg/l.
English: 8 mg/kg b/every 8 hours
Danish: 8 mg/kg b/hver 8. time
English: The incidence of DAGT seroconversion in patients receiving ceftaroline fosamil was 11.2% in the five pooled pivotal studies with administration every 12 hours (600 mg administered over 60 minutes every 12 hours) and 32.3% in a study in patients receiving ceftaroline fosamil every 8 hours (600 mg administered over 120 minutes every 8 hours), (see section 4.8).
Danish: Incidensen af DAT-serokonversion hos patienter, som fik behandling med ceftarolinfosamil i de fem puljede pivotalstudier med indgivelse hver 12. time (600 mg indgivet over 60 minutter hver 12. time), var 11,2 % og 32,3 % i et studie hos patienter, der fik behandling med ceftarolinfosamil hver 8. time (600 mg indgivet over 120 minutter hver 8. time) (se pkt.
English: Appropriate infusion diluents include: sodium chloride 9 mg/mL (0.9%) solution for injection, dextrose 50 mg/mL (5%) solution for injection, sodium chloride 4.5 mg/mL and dextrose 25 mg/mL solution for injection (0.45% sodium chloride and 2.5% dextrose) or Lactated Ringer's solution.
Danish: Egnede infusionsvæsker til fortynding omfatter: natriumchlorid 9 mg/ml (0,9 %) injektionsvæske, glucose 50 mg/ml (5 %) injektionsvæske, natriumchlorid 4,5 mg/ml og glucose 25 mg/ml injektionsvæske, (0,45 % natriumchlorid og 2,5 % glucose) og Ringer-lactatopløsning.
English: The resulting solution should be shaken prior to being transferred to an infusion bag or bottle containing either sodium chloride 9 mg/mL (0.9%) solution for injection, dextrose 50 mg/mL (5%) solution for injection, sodium chloride 4.5 mg/mL and dextrose 25 mg/mL solution for injection (0.45% sodium chloride and 2.5% dextrose) or Lactated Ringer's solution.
Danish: Den herved dannede opløsning skal rystes, inden den overføres til en infusionspose eller -flaske indeholdende enten natriumklorid 9 mg/ml (0,9 %) opløsning til injektion, glucose 50 mg/ml (5 %) opløsning til injektion, natriumklorid 4,5 mg/ml og glucose 25 mg/ml injektionsvæske, opløsning (0,45 % natriumklorid og 2,5 % glucose) eller Ringer-lactat-opløsning.
English: Talk to your doctor or nurse before using Zinforo:
Danish: Kontakt lægen, apotekspersonalet eller sundhedspersonalet, før du bruger Zinforo:
English: After reconstitution, 1 mL of the solution contains 30 mg of ceftaroline fosamil.
Danish: Efter rekonstitution indeholder 1 ml infusionsvæske 30 mg ceftarolinfosamil.
English: The pharmacokinetics of ceftaroline in patients with hepatic impairment has not been established.
Danish: Farmakokinetikken for ceftarolin hos patienter med nedsat leverfunktion er ikke blevet fastlagt.
English: The recommended dosages of Zinforo shown in Tables 1 to 4 for the treatment of cSSTI caused by S. aureus with ceftaroline MIC of 2 or 4 mg/L are based on pharmacokineticpharmacodynamic modelling and simulation (see sections 4.2 and 5.1).
Danish: De anbefalede doseringer af Zinforo, der er vist i tabel 1 til tabel 4 til behandling af cSSTI, der skyldes S. aureus med ceftarolin MIC på 2 eller 4 mg/l er baseret på farmakokinetisk/farmakodynamisk modellering og simulering (se pkt.
English: PK-PD analyses suggest that dosing of adults or adolescents (from 12 years and 33 kg) with ceftaroline every 8 hours using 2-hour infusions may treat cSSTI due to S. aureus for which the ceftaroline MIC is 4 mg/L.
Danish: Farmakokinetiske/farmakodynamiske analyser tyder på, at dosering til voksne eller unge (fra 12 år og 33 kg) med ceftarolin hver 8. time under anvendelse af 2-timers infusioner kan behandle cSSTI, der skyldes S. aureus, for hvilket ceftarolin MIC er 4 mg/l.
English: Infusion times of less than 60 minutes are based on pharmacokinetic and pharmacodynamic analyses only.
Danish: Infusionstider under 60 minutter er alene baseret på farmakokinetiske og farmakodynamiske analyser.
English: Table 1 Dosage in adults with normal renal function, creatinine clearance (CrCL) > 50 mL/min Indications
Danish: Tabel 1 Dosering til voksne med normal nyrefunktion, kreatininclearance (CrCL) > 50 ml/min
English: Adolescents aged from 12 years to < 18 years bodyweight < 33 kg and children ≥ 2 years to < 12 years
Danish: Unge i alderen 12 år til < 18 år med legemsvægt < 33 kg og børn ≥ 2 år til < 12 år
English: Ceftaroline or ceftaroline fosamil are not metabolised by CYP450 enzymes in vitro, therefore co-administered CYP450 inducers or inhibitors are unlikely to influence the pharmacokinetics of ceftaroline.
Danish: Ceftarolin og ceftarolinfosamil metaboliseres ikke af CYP450-enzymer in vitro, så samtidig behandling med CYP450-inducere eller -hæmmere påvirker sandsynligvis ikke farmakokinetikken for ceftarolin.
English: High dose cSSTI confirmed or suspected to be caused by S. aureus with an MIC = 2 mg/L or 4 mg/L to ceftaroline
Danish: Høj dosis cSSTI, som er bekræftet eller formodes at skyldes S. aureus med ceftarolin MIC = 2 mg/l eller 4 mg/l
English: • If you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine (listed in section 6).
Danish: • hvis du er allergisk over for ceftarolinfosamil eller et af de øvrige indholdsstoffer i Zinforo
English: Lab Test
Danish: Laboratorietest
English: Rash was observed at a common frequency in both the pooled Phase III studies in cSSTI with administration of Zinforo every 12 hours (600 mg administered over 60 minutes every 12 hours) and the study in cSSTI with administration every 8 hours (600 mg administered over 120 minutes every 8 hours).
Danish: Udslæt blev observeret med hyppigheden ”almindelig” i både de puljede fase III-cSSTI-studier med indgivelse af Zinforo hver 12. time (600 mg indgivet over 60 minutter hver 12. time) og i cSSTIstudiet med indgivelse hver 8. time (600 mg indgivet over 120 minutter hver 8. time).
English: There is insufficient information to recommend dosage adjustments in adolescents aged from 12 to < 18 years with bodyweight < 33 kg and in children aged from 2 to 12 years with End-stage renal disease (ESRD).
Danish: Der er utilstrækkelig information til at anbefale dosisjustering til unge i alderen fra 12 til < 18 år med en legemsvægt på < 33 kg og til børn i alderen fra 2 til 12 år med slutstadium af nyresygdom (ESRD).
English: A pale yellowish-white to light yellow powder.
Danish: Et svagt gulligt-hvidt til lysegult pulver.
English: Rash, pruritus Anaphylaxis, hypersensitivity (e.g. urticaria, lip and face swelling) (see sections 4.3 and 4.4)
Danish: Udslæt, pruritus Anafylaksi, overfølsomhed, (f.eks. urticaria, hævelse af læber og ansigt) (se pkt.
English: Refers to dosing of adults or adolescents (from 12 years and 33 kg) with ceftaroline every 12 hours using 1hour infusions (see section 4.2).
Danish: Henviser til dosering til voksne eller unge (fra 12 år og 33 kg) med ceftarolin hver 12. time under anvendelse af 1-times infusioner (se pkt.
English: Blood creatinine increased
Danish: Forhøjet serumkreatinin
English: There is insufficient information to recommend dosage adjustments in adolescents with ESRD aged from 12 to < 18 years and with bodyweight < 33 kg and in children with ESRD aged from 2 to < 12 years.
Danish: Der er utilstrækkelig information til at anbefale dosisjusteringer til unge med ESRD i alderen fra 12 til < 18 år og med en legemsvægt på < 33 kg og til børn med ESRD i alderen fra 2 til < 12 år.
English: Children and adolescents aged from ≥ 2 years to < 18 years
Danish: Børn og unge i alderen ≥ 2 år til < 18 år
English: There is insufficient information to recommend dosage adjustments in paediatric patients < 2 years with moderate or severe renal impairment or ESRD.
Danish: Der er utilstrækkelig information til at anbefale dosisjustering til pædiatriske patienter < 2 år med moderat eller svært nedsat nyrefunktion eller ESRD.
English: Dosage adjustments are required in adults, adolescents and children with CrCL ≤ 50 mL/min (see section 4.2).
Danish: Nedsat nyrefunktion Dosisjustering er nødvendig hos voksne, unge og børn med CrCL ≤ 50 ml/min (se pkt.
English: If you are not sure, talk to your doctor or nurse before using Zinforo.
Danish: Hvis du er i tvivl, så tal med din læge, apoteket eller sundhedspersonalet, før du bruger Zinforo.
English: Ceftaroline is a cephalosporin antibacterial with in vitro activity against Gram-positive and -negative bacteria.
Danish: Det har in vitro-aktivitet mod gram-positive og -negative bakterier.
English: • Chlamydophila spp.
Danish: • Chlamydophila arter
English: Instructions for the reconstitution of Zinforo vial are summarized below:
Danish: Nedenfor findes en vejledning til rekonstitution af Zinforo-hætteglas:
English: Clinical study experience with ceftaroline fosamil in patients with pre-existing seizure disorders is very limited.
Danish: Der er meget begrænset erfaring fra kliniske studier med ceftarolinfosamil til patienter med tidligere krampeanfald.
English: 12 mg/kg to a maximum of 400 mg b/every 8 hours
Danish: 12 mg/kg, dog højst 400 mg b/hver 8. time
English: Rare (may affect up to 1 in 1,000 people)
Danish: Sjælden (kan forekomme hos op til 1 ud af 1.000 personer)
English: There is insufficient information to recommend dosage adjustments in paediatric patients aged < 2 years with moderate or severe renal impairment or ESRD.
Danish: Der er utilstrækkelig information til at anbefale dosisjusteringer til pædiatriske patienteri alderen < 2 år med moderat eller svært nedsat nyrefunktion eller ESRD.
English: Refers to dosing of adults or adolescents (from 12 years and 33 kg) with ceftaroline every 8 hours using 2hour infusions to treat cSSTI (see section 4.2).
Danish: Henviser til dosering til voksne eller unge (fra 12 år og 33 kg) med ceftarolin hver 8. time under anvendelse af 2-timers infusioner til behandling af cSSTI (se pkt.
English: Each vial contains ceftaroline fosamil acetic acid solvate monohydrate equivalent to 600 mg ceftaroline fosamil.
Danish: Hvert hætteglas indeholder ceftarolinfosamilmonoacetatmonohydrat svarende til 600 mg ceftarolinfosamil (ceftarolinum fosamilum).
English: If you use more Zinforo than you should If you think you have been given too much Zinforo, tell your doctor or nurse straight away.
Danish: Hvis du mener, at du har fået for meget Zinforo, skal du straks fortælle det til lægen, apoteket eller sundhedspersonalet.
English: Infusion times of less than 60 minutes and high dose recommendations are based on pharmacokinetic and pharmacodynamic analyses only.
Danish: Infusionstid under 60 minutter og anbefalinger for høj dosis er alene baseret på farmakokinetiske og farmakodynamiske analyser.
English: Gram-negative micro-organisms
Danish: Gramnegative mikroorganismer
English: • If you have ever had fits (seizures or convulsions)
Danish: • hvis du nogensinde har haft krampeanfald
English: Hypersensitivity to the cephalosporin class of antibacterials.
Danish: Overfølsomhed over for antibakterielle midler i gruppen af cefalosporiner.
English: 8 mg/kg to a maximum of 300 mg c/every 8 hours
Danish: 8 mg/kg, dog højst 300 mg c/hver 8. time
English: Table 4 Dosage in paediatric patients with impaired renal function, creatinine clearance
Danish: Tabel 2 Dosering til pædiatriske patienter med normal nyrefunktion, kreatininclearance
English: Standard aseptic techniques should be used for solution preparation and administration.
Danish: Opløsningen skal fremstilles og indgives ved brug af aseptiske standardteknikker.
English: No dosage adjustment is required for the elderly with creatinine clearance values > 50 mL/min (see section 5.2).
Danish: Dosisjustering er ikke nødvendig hos ældre patienter med kreatininclearanceværdier > 50 ml/min (se pkt.
English: • Legionella spp.
Danish: • Legionella arter
English: Positive (see section 4.4)
Danish: 4.3 og 4.4)
English: Complicated skin and soft tissue infections (cSSTI)
Danish: Komplicerede hud- og bløddelsinfektioner (cSSTI)
English: See leaflet for shelf life after reconstitution.
Danish: Se indlægssedlen for oplysninger om opbevaringstid efter rekonstitution.
English: Community-acquired pneumonia
Danish: Samfundserhvervet pneumoni
English: Infusion times of less than 60 minutes, neonatal and high dose recommendations are based on pharmacokinetic and pharmacodynamic analyses only.
Danish: Infusionstid under 60 minutter og anbefalinger for nyfødte og høj dosis er alene baseret på farmakokinetiske og farmakodynamiske analyser.
English: What Zinforo is
Danish: Hvad er Zinforo?
English: When ceftaroline was administered during organogenesis, minor changes in foetal weight and delayed ossification of the interparietal bone were observed in the rat at exposures below that observed clinically.
Danish: Der blev observeret mindre ændringer i fostervægt og forsinket ossifikation i interparietalknoglen hos rotter ved niveauer under den observerede kliniske eksponering, når ceftarolin blev administreret under organogenesen.
English: Tell your doctor before using Zinforo if you are pregnant.
Danish: Hvis du er gravid, skal du fortælle det til din læge, før du bruger Zinforo.
English: If you miss a dose of Zinforo If you think you have missed a dose, tell your doctor or nurse straight away.
Danish: Hvis du mener, at du mangler at få en dosis, skal du straks fortælle det til lægen eller sundhedspersonalet.
English: 12 mg/kg to a maximum of 600 mg
Danish: 12 mg/kg, dog højst 600 mg
English: 10 mg/kg to a maximum of 400 mg
Danish: 10 mg/kg, dog højst 400 mg
English: 8 mg/kg to a maximum of 300 mg
Danish: 8 mg/kg, dog højst 300 mg
English: How to use Zinforo
Danish: Sådan skal du bruge Zinforo
English: What Zinforo looks like and contents of the pack Zinforo is a pale yellowish-white to light yellow powder for concentrate for solution for infusion in a vial.
Danish: Zinforo er et hætteglas med svagt gulligt-hvidt til lysegult pulver til koncentrat til infusionsvæske, opløsning.
English: Zinforo 600 mg powder for concentrate ceftaroline fosamil
Danish: Zinforo 600 mg pulver til koncentrat ceftarolinum fosamilum i.v.
English: • Proteus spp.
Danish: • Proteus arter
English: Once the intravenous solution is prepared with diluents listed in section 6.6 it should be administered within 6 hours of preparation.
Danish: 6.6, skal infusionsopløsningen indgives inden for 6 timer.
English: What Zinforo is and what it is used for What you need to know before you use Zinforo How to use Zinforo
Danish: Det skal du vide, før du begynder at bruge Zinforo Sådan skal du bruge Zinforo Bivirkninger
English: 6 mg/kg to a maximum of 200 mg
Danish: 6 mg/kg, dog højst 200 mg
English: Common Uncommon
Danish: Ikke almindelig
English: Zinforo 600 mg powder for concentrate for solution for infusion
Danish: Zinforo 600 mg pulver til koncentrat til infusionsvæske, opløsning.
English: Zinforo 600 mg powder for concentrate for solution for infusion ceftaroline fosamil
Danish: Zinforo 600 mg pulver til koncentrat til infusionsvæske, opløsning ceftarolinum fosamilum
English: • Each vial contains 600 mg of ceftaroline fosamil.
Danish: • Aktivt stof: Hvert hætteglas indeholder 600 mg ceftarolinfosamil.
English: • If you have ever had any non-severe allergic reactions to other antibiotics like penicillin or carbapenem
Danish: • hvis du nogensinde har haft ikke-alvorlige allergiske reaktioner over for andre antibiotika,
English: A greater incidence of rash in Asian patients (see below) and a greater incidence of DAGT seroconversion (see section 4.4) were observed in a study of adult patients with cSSTI conducted with Zinforo 600 mg administered over 120 minutes every 8 hours.
Danish: 4.4) blev observeret i en undersøgelse med voksne patienter med cSSTI udført med Zinforo 600 mg og administreret i løbet af 120 minutter hver 8. time
English: • Peptostreptococcus spp.
Danish: • Peptostreptococcus arter
English: • Mycoplasma spp.
Danish: • Mycoplasma arter
English: • Anaemia
Danish: • Svimmelhed
English: Ceftaroline is haemodialyzable; thus Zinforo should be administered after haemodialysis on haemodialysis days.
Danish: Derfor bør Zinforo administreres efter hæmodialyse på hæmodialysedage.
English: Table 3 Dosage in adults with impaired renal function, creatinine clearance (CrCL)
Danish: Tabel 3 Dosering til voksne med nedsat nyrefunktion, kreatininclearance (CrCl) ≤ 50 ml/min) Indikation
English: The patient will usually take their medicine for at least 6 to 12 months, and treatment may last several years.
Danish: Patienterne tager typisk lægemidlet i mindst 6-12 måneder, og behandlingen kan vare adskillige år.
English: The full EPAR for Vemlidy can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Danish: Den fuldstændige EPAR for Vemlidy findes på agenturets websted under: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: If this protein is present, it means that the virus is multiplying rapidly and the viral load may be higher.
Danish: Hvis proteinet er til stede, betyder det, at virusset formerer sig hurtigt, og virusbelastningen kan være højere.
English: This medicine is used in patients aged 12 years and older weighing at least 35 kg.
Danish: Det anvendes hos patienter, der er 12 år eller derover, og som vejer mindst 35 kg.
English: This is a summary of the European public assessment report (EPAR) for Vemlidy.
Danish: Dette dokument er et sammendrag af den europæiske offentlige vurderingsrapport (EPAR) for Vemlidy.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) therefore concluded that the benefits of Vemlidy outweigh its risks and recommended its approval in the EU.
Danish: Agenturets Udvalg for Lægemidler til Mennesker (CHMP) konkluderede derfor, at fordelene ved Vemlidy er større end risiciene, og anbefalede, at det godkendes til anvendelse i EU.
English: For the full list of side effects and restrictions see the package leaflet.
Danish: Den fuldstændige liste over bivirkninger og begrænsninger fremgår af indlægssedlen.
English: The most common side effects with Vemlidy are headache (11% of patients), nausea (6% of patients) and tiredness (6% of patients).
Danish: De hyppigste bivirkninger ved Vemlidy er hovedpine (11 % af patienterne), kvalme (6 % af patienterne) og træthed (6 % af patienterne).
English: Vemlidy is available as 25 mg tablets which are taken by mouth (one tablet a day) with food.
Danish: Vemlidy fås som 25 mg-tabletter, der tages gennem munden (én tablet pr. dag) sammen med mad.
English: These results suggest that the comparator medicine might be more effective in ‘e-antigen positive' cases but differences seen are small.
Danish: Disse resultater tyder på, at sammenligningspræparatet måske er mere effektivt hos patienter med "e-antigen-positiv"-virus, men de observerede forskelle er små.
English: Other information about Vemlidy
Danish: Andre oplysninger om Vemlidy
English: What measures are being taken to ensure the safe and effective use of Vemlidy?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv anvendelse af Vemlidy?
English: Vemlidy can only be obtained with a prescription.
Danish: Vemlidy udleveres kun efter recept.
English: The terms ‘e-antigen positive' and ‘e-antigen negative' refer to the presence or absence of e-antigen, a hepatitis B viral protein.
Danish: Begreberne "e-antigen-positiv" og "e-antigen-negativ" henviser til, om virusset har eller ikke har eantigenet, der er et hepatitis B-viralt protein.
English: Vemlidy tenofovir alafenamide
Danish: Vemlidy tenofoviralafenamid
English: In addition, Vemlidy is effective at a lower dose than tenofovir disoproxil fumarate and may lead to reduced side effects in the kidneys and bones.
Danish: Vemlidy er desuden effektivt ved en lavere dosis end tenofovirdisoproxilfumarat og kan føre til reducerede bivirkninger i nyrer og knogler.